Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-465-2 | CAS number: 8047-99-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity (OECD TG 401): LD50 >5800 mg/kg bw
Acute dermal toxicity (OECD TG 402): LD50 >7945 mg/kg bw
Acute inhalation toxicity: not classified
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 Aug 1985 - 03 Sep 1985
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (adopted 12 May 1981)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Specific details on test material used for the study:
- - Chemical name: N-substituted toluene sulphonamide
- Trade name/code: Ketjenflex 8
- Impurity: Approx. 10% o/p toluene sulfonamide
- Specific gravity: Approx. 1200 kg/m3 (at 25 ̊ C)
- Solubility: Organic solvents except petroleum hydrocarbons
- Flash point: 224 ̊ C
- Boiling point: > 340 ̊ C
- Vapour pressure: < 1mm Hg at 150 ̊ C
- Appearance: Light yellow, viscous liquid
- Storage: At ambient temperature in the dark
- Stability: Practically unlimited - Species:
- rat
- Strain:
- Wistar
- Remarks:
- SPF quality - randomly bred
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Central institute for the Breeding of Laboratory Animals TNO (CPB), Zeist, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: No information provided
- Age at study initiation: No information provided
- Weight at study initiation: Males: from 206 to 241 g. Females: from 136 to 157 g
- Fasting period before study: Feed was withheld overnight before dosing till approximately 3.5 to 5 hours after administration of the test substance.
- Housing: Animals were individually housed in Macrolon cages (acclimation period). The bedding material, purified saw dust (woody clean), was received from The Broekman Institute, Someren, The Netherlands.
- Diet (e.g. ad libitum): Standard laboratory animal diet (RMH-B, pellet diameter 10 mm), which was obtained from Hope Farms, Woerden, The Netherlands.
- Water (e.g. ad libitum): free access to tap water
- Acclimation period: Quarantine period was 8 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 22
- Humidity (%): Relative humidity 50-80
- Photoperiod (hrs dark / hrs light): The artificial light sequence was 12 hours light, 12 hours dark. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 13.0 g/Kg Body weight
DOSE RANGE FINDING INVESTIGATION:
- Rationale for the selection of the starting dose: In order to establish an appropriate dose range three groups of Wistar rats, each compromising 1 male and 1 female, were dosed with a single oral dose of the test substance at 5000, 4200 and 3200 mg/Kg body weight, respectively. The female of the 4200 mg/Kg group was found dead on day 1. All animals showed signs of systemic toxicity (apathy, and reduced locomotive activity). As of day 1 no more abnormalities were observed during the 9-day observation period. Macroscopic examination at autopsy of the animal found dead showed bloody contents of the ileum; surviving animals revealed no gross abnormalities at autopsy. - Doses:
- Single oral dose of the test substance at 4.2, 7.4 and 13.0 g/Kg body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of weighing: Day 0, 7 and 14
- Necropsy of survivors performed: no information provided
- Other examinations performed: clinical signs, body weight and pathology - Statistics:
- LD50 calculation according to maximum likelihood (FINNEY)
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 5.8 other: g/kg/ bw
- Based on:
- test mat.
- 95% CL:
- >= 4.4 - <= 7.4
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 6.9 other: g/Kg/ bw
- Based on:
- test mat.
- 95% CL:
- >= 5.9 - <= 10
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 4.8 other: g/Kg/ bw
- Based on:
- test mat.
- 95% CL:
- >= 0 - <= 7.5
- Mortality:
- In the low dose group 2 out of 10 animals died, in the medium dose group 7 out of 10 and in the high dose group 10 out of 10. There was insufficient data to assess a sex related effect. All deaths occurred within 3 days of dosing.
- Clinical signs:
- other: Signs of toxicity were apathy, reduced locomotive activity, labored breathing, tremors, or reduced or bloody faecal excretion. For surviving animals these signs were reversible since as of day 4 no more abnormalities were observed during the 14 days obser
- Gross pathology:
- Macroscopic observations at autopsy of animals found dead after day 1 revealed in 3 males and 4 females petechiae or haemorrhages of the stomach wall. In addition, 1 male and 4 females showed superficial liver necrosis in areas adjacent to the stomach, and 4 females showed marked haematuria. These findings were indicative of stomach perforation and damage to the urogenital tract, respectively. In 10 animals found dead on day 1 and in all animals sacrificed at the end of observation period, no treatment related gross abnormalities were observed.
- Interpretation of results:
- other: not classified
- Remarks:
- according to the EU classification criteria outlined in Annex I of 1272/2008/EC (CLP)
- Conclusions:
- The LD50 value of Ketjenflex 8 for the sexes combined amounted to approximately 5.8 g/kg body weight with a 95% confidence limit (4.4 -7.4 g/Kg body weight).
- Executive summary:
Three groups of Wistar rats, each comprising of 5 males and 5 females, received a single oral dose of ketjenflex 8 at 4.2, 7.4 and 13.0 g/Kg body weight, respectively. In the low dose group 2 out of 10 animals died, in the medium dose group 7 out of 10 and in the high dose group 10 out of 10. There was insufficient data to assess a sex related effect. All deaths occurred within 3 days of dosing. Signs of toxicity were apathy, reduced locomotive activity, labored breathing, tremors, or reduced or bloody faecal excretion. For surviving animals these signs were reversible, at day 4 no more abnormalities were observed during the 14 days observation. Animals found dead showed body weight loss whereas surviving animals showed normal weekly body weight gain. Macroscopic observations at autopsy of animals found dead after day 1 revealed petechiae or haemorrhages of the stomach wall, superficial liver necrosis in areas adjacent to the stomach, and marked haematuria. These findings were indicative of stomach perforation and damage to the urogenital tract. Animals found dead on day 1 and in all animals sacrificed at the end of the study showed no treatment related gross abnormalities were observed. While the calculated LD50 for males and female were 6.9 mg/kg bw (95% CI: 5.9 - 10.0 mg/kg bw) and 4.8 mg/kg bw (95% CI: 0 - 7.5 mg/kg bw) respectively. The acute oral LD50 for the substance in male and female rats was determined to be 5.8 g/kg bw with 95% CI of 4.4 -7.4 mg/kg bw.
As a result, the substance N-Ethyl-o (or p)-toluenesulfonamide (NETSA) does not need to be classified for acute oral toxicity according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 800 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1958
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-guideline study, pre-GLP, doses not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- not specified
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Details on inhalation exposure:
- Animals were exposed for 3 consecutive days of 8 hours.
- No. of animals per sex per dose:
- 4
- Control animals:
- no
- Key result
- Sex:
- male
- Dose descriptor:
- other: saturated vapours at 177 deg C.
- Based on:
- test mat.
- Exp. duration:
- 8 h
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- None
- Clinical signs:
- other: Moderate discomfort, slight nasal discharge, inflammation, letargy.
- Interpretation of results:
- other: not classified
- Remarks:
- according to the EU classification criteria outlined in Annex I of 1272/2008/EC (CLP)
- Conclusions:
- No deaths occured in a 3 consecutive day 8 hours exposure of air saturated by Santicizer 8 vapours at 177 deg C .
- Executive summary:
Four mature male rats (Sprague-Dawley) were placed in a metal chamber of approximately 35 liters for three consecutive eight hour days to a saturated atmosphere of Sanitizer 8 vapours produced by heating the liquid to 350 deg F (177 deg C). 250 mL of sample was placed in a three hals round bottom flask and the vapours were led into the chamber through a short lenght of hose. A gas burner was used to maintain the proper temperature. Food and water were applied ad lib. Observations were done for behaviour and since there were no deaths, all animals were held for seven days following the test. The average temperature inside the chamber was 76.0 deg F and the average humidity was 58.0%.
No deaths resulted from the three days exposure. Whitish, aury vapours were given off at a sufficient rate to maintain a moderate inside the chamber. In all probability the atmosfere was kept saturated. Mild discomfort was noted within a few minutes after the start of each days exposure. This developed into moderate lethargy with mild to moderate inflammation of the nasal route. Breating remained about normal. There was moisteming of the nasal passages but only slight discharge. The animals looked normal at the start of each days test and no compications developed during a seven day holding period. The compound becomes dark in colour in one to two hours after being heated. It was comcluded that Santicizer 8 vapours given off at 350 deg F.are moderately irritating in a saturated atmoshere. They were not acutely toxic to rats.
As a result, the substance N-Ethyl-o (or p)-toluenesulfonamide (NETSA) does not need to be classified for acute inhalation toxicity according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Reference
No deaths resulted from the three days exposure. Whitish, aury vapours were given off at a sufficient rate to maintain a moderate inside the chamber. In all probability the atmosfere was kept saturated. Mild discomfort was noted within a few minutes after the start of each days exposure. This developed into moderate lethargy with mild to moderate inflammation of the nasal route. Breating remained about normal. There was moisteming of the nasal passages but only slight discharge. The animals looked normal at the start of each days test and no compications developed during a seven day holding period. The compound becomes dark in colour in one to two hours after being heated. It was comcluded that Santicizer 8 vapours given off at 350 deg F.are moderately irritating in a saturated atmoshere. They were not acutely toxic to rats.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1976
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: pre-GLP
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- other: Not specified
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Initial weight:
- Male: 1.9 kg
- Female: 1.8 and 2.2
Details on other conditions and test animal was not provided - Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- Applied undiluted
- Details on dermal exposure:
- Information not provided
- Duration of exposure:
- 24 hours
- Doses:
- 5,010 and 7,940 Mg/Kg
- No. of animals per sex per dose:
- 1
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: no information
- Necropsy of survivors performed: no information
- Other examinations performed: signs of intoxication, gross autopsy decedents, survivors - Statistics:
- No information
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 7 940 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Reduced appetite and activity ( three to five days)
- Other findings:
- Survivors ( 14 days): Viscera appeared normal
- Interpretation of results:
- other: Not classified
- Remarks:
- according to the EU classification criteria outlined in Annex I of 1272/2008/EC (CLP)
- Conclusions:
- The LD50 of Santicizer 8 in rabbits after 24 hours was > 7940 mg/kg bw under the conditions of this test.
- Executive summary:
To determine the dermal toxicity of Santicizer 8, an acute dermal toxicity study was performed on three New Zealand albino rabbits at a dosage level of 5010 and 7940 mg/kg bw. The LD50 of the test substance after 24 hours was > 7940 mg/kg bw under the conditions of this test. Santicizer 8 therefore does not have to be classified for acute dermal toxicity.
As a result, the substance N-Ethyl-o (or p)-toluenesulfonamide (NETSA) does not need to be classified for acute dermal toxicity according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 7 945 mg/kg bw
Additional information
Acute oral toxicity (OECD TG 401)
Three groups of Wistar rats, each comprising of 5 males and 5 females, received a single oral dose of Ketjenflex 8 at 4.2, 7.4 and 13.0 g/Kg body weight, respectively. In the low dose group 2 out of 10 animals died, in the medium dose group 7 out of 10 and in the high dose group 10 out of 10. There was insufficient data to assess a sex related effect. All deaths occurred within 3 days of dosing. Signs of toxicity were apathy, reduced locomotive activity, labored breathing, tremors, or reduced or bloody faecal excretion. For surviving animals these signs were reversible, at day 4 no more abnormalities were observed during the 14 days observation. Animals found dead showed body weight loss whereas surviving animals showed normal weekly body weight gain. Macroscopic observations at autopsy of animals found dead after day 1 revealed petechiae or haemorrhages of the stomach wall, superficial liver necrosis in areas adjacent to the stomach, and marked haematuria. These findings were indicative of stomach perforation and damage to the urogenital tract. Animals found dead on day 1 and in all animals sacrificed at the end of the study showed no treatment related gross abnormalities were observed. While the calculated LD50 for males and female were 6.9 mg/kg bw (95% CI: 5.9 - 10.0 mg/kg bw) and 4.8 mg/kg bw (95% CI: 0 - 7.5 mg/kg bw) respectively. The acute oral LD50 for the substance in male and female rats was determined to be 5.8 g/kg bw with 95% CI of 4.4 -7.4 mg/kg bw. As a result, the substance does not need to be classified according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Acute dermal toxicity (OECD TG 402)
To determine the dermal toxicity of Santicizer 8, an acute dermal toxicity study was performed on three New Zealand albino rabbits at a dosage level of 5010 and 7940 mg/Kg. The LD50 of the test substance after 24 hours was > 7940 mg/kg bw under the conditions of this test. Santicizer 8 therefore does not have to be classified according to the EU classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Acute inhalation toxicity
Four mature male rats (Sprague-Dawley) were placed in a metal chamber of approximately 35 liters for three consecutive eight hour days to a saturated atmosphere of Sanitizer 8 vapours produced by heating the liquid to 350 deg F (177 deg C). 250 mL of sample was placed in a three hals round bottom flask and the vapours were led into the chamber through a short lenght of hose. A gas burner was used to maintain the proper temperature. Food and water were applied ad lib. Observations were done for behaviour and since there were no deaths, all animals were held for seven days following the test. The average temperature inside the chamber was 76.0 deg F and the average humidity was 58.0%.
No deaths resulted from the three days exposure. Whitish, aury vapours were given off at a sufficient rate to maintain a moderate inside the chamber. In all probability the atmosfere was kept saturated. Mild discomfort was noted within a few minutes after the start of each days exposure. This developed into moderate lethargy with mild to moderate inflammation of the nasal route. Breating remained about normal. There was moisteming of the nasal passages but only slight discharge. The animals looked normal at the start of each days test and no compications developed during a seven day holding period. The compound becomes dark in colour in one to two hours after being heated. It was comcluded that Santicizer 8 vapours given off at 350 deg F.are moderately irritating in a saturated atmoshere. They were not acutely toxic to rats.
The substance does not have to be classified for acute inhalation toxicity according to the EU classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Justification for classification or non-classification
Based on the available information, N-ethyl-o/p-toluenesulfonamide (NETSA) does not need to be classified for acute oral, dermal and inhalation toxicity, according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.